Novel biomarkers for the diagnosis of urinary tract infection-a systematic review.
Urinary tract infections (UTIs) are associated with significant morbidity. We rely on clinical presentation, urinalysis, and urine culture to diagnose UTI. To differentiate between lower UTI and pyelonephritis, we depend on the clinical presentation. In the extremes of age and in immunocompromised individuals, clinical presentation is often atypical posing a challenge to diagnosis. In the elderly, the high prevalence of asymptomatic bacteriuria is another confounder. We conducted a search of publications to find novel biomarkers to diagnose UTI and to ascertain its severity. We searched PUBMED, MEDLINE and SCOPUS databases for studies pertaining to novel biomarkers and UTI. Two reviewers independently evaluated the methodology of the studies using the STARD (Standards for Reporting of Diagnostic Accuracy) criteria. We have identified procalcitonin as a biomarker to differentiate lower UTI from pyelonephritis in the pediatric age group. Elevated serum procalcitonin levels can result in early and aggressive treatment at the time of presentation. Interleukin 6 has also shown some promise in differentiating between lower UTI and pyelonephritis but needs further validation. Lastly, given the paucity of data in certain subgroups like diabetics, kidney transplant recipients, and individuals with spinal cord injury, further studies should be conducted in these populations to improve diagnostic criteria that will inform clinical management decisions.
Nanda
Neha
N
Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA. Email: neha.nanda@yale.edu.
Juthani-Mehta
Manisha
M
Pediatr Nephrol. 2009 Jun;24(6):1199-204
19205751
Arch Intern Med. 2000 Mar 13;160(5):678-82
10724054
Kidney Int. 2005 Jul;68(1):62-70
15954896
Arch Dis Child. 2001 Sep;85(3):256-62
11517116
Indian J Pediatr. 2004 Jan;71(1):37-40
14979384
Cytokine. 2005 Sep 21;31(6):415-8
16115778
Pediatrics. 2004 Aug;114(2):e249-54
15286264
N Engl J Med. 2003 Jan 16;348(3):195-202
12529459
Pediatr Nephrol. 2005 Oct;20(10):1445-8
16079986
Pediatrics. 2000 Feb;105(2):E28
10654988
J Infect. 2007 Jun;54(6):e249-50
17343917
Pediatr Nephrol. 2001 Sep;16(9):733-8
11511988
Cytokine. 2006 Dec;36(5-6):276-82
17374489
Nucl Med Commun. 2006 Sep;27(9):715-21
16894326
Biol Neonate. 2002;81(2):109-12
11844880
Int Urol Nephrol. 2009;41(2):393-9
18836845
Kidney Int. 1998 Oct;54(4):1331-6
9767552
Med Sci Monit. 2004 Nov;10(11):CR593-7
15507849
Pediatr Infect Dis J. 2001 May;20(5):507-11
11368108
J Pediatr. 2007 Jan;150(1):89-95
17188622
Curr Infect Dis Rep. 2008 Nov;10(6):499-504
18945392
Lancet. 1993 Feb 27;341(8844):515-8
8094770
Clin Pharmacol Ther. 2001 Mar;69(3):89-95
11240971
J Urol. 1991 Mar;145(3):542-6
1847727
Pediatr Nephrol. 2002 Jun;17(6):409-12
12107804
J Infect Dis. 1999 Sep;180(3):904-7
10438391
Eur J Pediatr. 2005 Oct;164(10):651-2
16025299
Pediatr Nephrol. 2007 Jul;22(7):1002-6
17375337
Ann Intern Med. 2003 Jan 7;138(1):W1-12
12513067
Nephrology (Carlton). 2007 Oct;12(5):487-93
17803473
Pediatr Nephrol. 2000 Dec;15(3-4):236-40
11149117
J Clin Microbiol. 1999 Mar;37(3):553-7
9986811
Spinal Cord. 1998 Apr;36(4):266-74
9589527
Infect Control Hosp Epidemiol. 2007 Jul;28(7):889-91
17564998
Spinal Cord. 1998 Jan;36(1):33-8
9471136
BMJ. 1989 Sep 16;299(6701):703-6
2508881
Transplant Proc. 2005 Jul-Aug;37(6):2823-5
16182820
Pediatrics. 1998 Dec;102(6):1422-5
9832579
Infection. 2001 Oct;29(5):274-7
11688906
Arch Intern Med. 2005 Nov 28;165(21):2514-20
16314549
Pediatr Infect Dis J. 2003 May;22(5):438-42
12792386
Postgrad Med. 1992 Feb 1;91(2):261-8
1738745
Immunol Invest. 2008;37(7):694-703
18821216
Transplantation. 1997 Aug 15;64(3):443-7
9275111